Study sheds light on a potential new strategy to prevent fatty liver

FHS
October 7, 2024
12:24 pm

The accumulation of fats in the liver is driven by high-fat diets and obesity, and is becoming an increasingly prevalent global health concern.

Eli Lilly concludes Morphic acquisition for IBD portfolio expansion

The acquisition will aid Lilly in enhancing treatment options for individuals suffering from IBD. Credit: Tada Images/Shutterstock. Eli Lilly and Company has concluded the acquisition

August 19, 2024

Opinion | Now Is Not the Time to Undo Adolescent Vaccination Policies

Hughes is an attorney who writes and teaches in the areas of biopharmaceutical and disease prevention policy. At a time when routine vaccination rates have

November 8, 2024

GSK wins second Zantac cancer case to go to trial

GSK was found not liable in the second jury trial involving the company’s heartburn medication, Zantac. The company said in a Sign up to read

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.